GC
MATN

Guggenheim Capital’s Mateon Therapeutics, Inc. MATN Stock Holding History

Guggenheim Capital’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,948
Closed -$10K – 2956
2016
Q2 		$10K Buy
+13,948
New +$10K ﹤0.01% 2848